Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial DOI
Amit G. Singal, Manasa Narasimman, Darine Daher

и другие.

Gut, Год журнала: 2024, Номер unknown, С. gutjnl - 332508

Опубликована: Июнь 5, 2024

Background Hepatocellular carcinoma (HCC) is plagued by failures across the cancer care continuum, leading to frequent late-stage diagnoses and high mortality. We evaluated effectiveness of mailed outreach invitations plus patient navigation promote HCC screening process completion in patients with cirrhosis. Methods Between April 2018 September 2021, we conducted a multicentre pragmatic randomised clinical trial comparing for (n=1436) versus usual visit-based among cirrhosis at three US health systems. Our primary outcome was over 36-month period, our secondary proportion time covered (PTC) screening. All were included intention-to-screen analyses. Results 2872 participants (median age 61.3 years; 32.3% women) Screening observed 6.6% (95% CI: 5.3% 7.9%) 3.3% 2.4% 4.3%) those (OR 2.05, 95% 1.44 2.92). The intervention increased most subgroups including age, sex, race ethnicity, Child-Turcotte-Pugh class system. PTC also significantly higher arm than (mean 37.5% vs 28.2%; RR 1.33, 1.31 1.35). Despite underuse, both arms detected an early stage. Conclusion Mailed cirrhosis, consistent effect examined subgroups. However, remained suboptimal arms, underscoring need more intensive interventions. Trial registration number NCT02582918 .

Язык: Английский

Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy DOI
Amit G. Singal, Fasiha Kanwal, Josep M. Llovet

и другие.

Nature Reviews Clinical Oncology, Год журнала: 2023, Номер 20(12), С. 864 - 884

Опубликована: Окт. 26, 2023

Язык: Английский

Процитировано

346

Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology DOI
Daniel Q. Huang, Amit G. Singal, Fasiha Kanwal

и другие.

Nature Reviews Gastroenterology & Hepatology, Год журнала: 2023, Номер 20(12), С. 797 - 809

Опубликована: Авг. 3, 2023

Язык: Английский

Процитировано

90

Latest advances in hepatocellular carcinoma management and prevention through advanced technologies DOI Creative Commons

Tamer A. Addissouky,

Ibrahim El Tantawy El Sayed, Majeed M. A. Ali

и другие.

Egyptian Liver Journal, Год журнала: 2024, Номер 14(1)

Опубликована: Янв. 2, 2024

Abstract Background Hepatocellular carcinoma (HCC) is a common type of liver cancer, with high mortality rate. cancer that can be effectively managed through early detection and accurate diagnosis, followed by personalized treatment plan may include surgical resection, transplantation, minimally-invasive techniques, immunotherapy, or targeted therapy depending on the stage severity cancer. Main body abstract This paper discusses recent advances in detection, management, prevention HCC. The use newer imaging such as Magnetic resonance (MRI) contrast-enhanced ultrasound, along image segmentation technology deep learning models, have greatly enhanced accuracy HCC diagnosis. Minimally-invasive thermal ablation radiofrequency ablation, allowed for more precise destruction tumors, while Nanoparticles, immunotherapy shown promise management advanced Artificial intelligence (AI) machine has revolutionized research, aiding identification high-risk patients predicting outcomes. Lifestyle modifications, weight alcohol avoidance, hepatitis B vaccinations, play critical role preventing development. Short conclusion Recent improving patient therapy, AI research lifestyle modifications prevention. However, further required to fully understand potential benefits nanoparticles, traditional Chinese medicine herbal medicines treatment. Graphical

Язык: Английский

Процитировано

35

Rapid Detection of Alpha-Fetoprotein (AFP) with Lateral Flow Aptasensor DOI Creative Commons

Meijing Ma,

Min Zhang,

Jiahui Wang

и другие.

Molecules, Год журнала: 2025, Номер 30(3), С. 484 - 484

Опубликована: Янв. 22, 2025

We present a lateral flow aptasensor for the visual detection of alpha-fetoprotein (AFP) in human serum. Leveraging precise molecular recognition capabilities aptamers and distinct optical features gold nanoparticles, model system utilizing AFP as target analyte, along with pair aptamer probes, is implemented to establish proof-of-concept on standard test strips. It first report an antibody-free assay using probes AFP. The analysis circumvents numerous incubation washing steps that are typically involved most current aptamer-based protein assays. Qualitative involves observing color changes area, while quantitative data obtained by measuring response zone portable strip reader. biosensor exhibits linear range concentrations between 10 100 ng/mL, minimum limit ng/mL. Additionally, it has been successfully applied detect serum samples. use aptamer-functionalized nanoparticle offers great promise point-of-care applications fast, on-site detection.

Язык: Английский

Процитировано

2

5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation DOI Creative Commons

Danjun Song,

Zhou Zhang,

Jiaping Zheng

и другие.

Biomarker Research, Год журнала: 2025, Номер 13(1)

Опубликована: Март 7, 2025

Abstract Developing accurate, clinically convenient, and non-invasive methods for early cancer detection, monitoring, prognosis assessment is essential improving patient survival rates, enhancing quality of life, reducing the socioeconomic burden associated with cancer. This goal critical in precision oncology. Genetic epigenetic alterations circulating cell-free DNA (cfDNA) have emerged as transformative tools advancing outcomes. Among these, 5-hydroxymethylcytosine (5hmC) modifications cfDNA stand out promising markers, offering insights into initiation, progression, metastasis, across various types, such lung cancer, colorectal hepatocellular carcinoma. review comprehensively explores biology sequencing methodologies 5hmC, emphasizing their potential screening, diagnosis, treatment prognostic assessment. It highlights recent advancements cfDNA-derived 5hmC signatures’ applications, addressing strengths limitations context clinical translation. Furthermore, this outlines key challenges future directions integrating routine practice, facilitating personalized management.

Язык: Английский

Процитировано

2

International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance DOI Open Access
Amit G. Singal, Marco Sanduzzi‐Zamparelli, Pierre Nahon

и другие.

Journal of Hepatology, Год журнала: 2023, Номер 79(1), С. 226 - 239

Опубликована: Фев. 26, 2023

Язык: Английский

Процитировано

40

Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis DOI
Manasa Narasimman, Rubén Hernáez,

Vanessa Cerda

и другие.

Hepatology, Год журнала: 2023, Номер 79(1), С. 107 - 117

Опубликована: Июль 4, 2023

Background and Aims: The value of HCC surveillance is determined by the balance between benefits harms; however, no studies have enumerated psychological harms. Approach Results: We fielded surveys measuring harms to patients with cirrhosis in a multicenter randomized trial outreach. All positive or indeterminate results matched negative were invited complete (1) depression through Patient Health Questionnaire-ninth version, (2) anxiety State-Trait Anxiety Inventory, (3) HCC-specific worry Psychological Consequences Questionnaire, (4) decisional regret. Patients classified into 4 groups: true (TP), false (FP), indeterminate, (TN). Multivariable longitudinal regression analysis using generalized estimating equation method was performed compare means measures across groups. conducted 89 semistructured interviews subset stratified health system test results. Of 2872 trial, 311 completed 1+ follow-up survey (63 FP, 77 38 TP, 133 TN). Moderate decreased TN patients, increased had intermittent but mild increases those FP High temporarily TP resolved over time stable Decisional regret low did not differ In interviews, reported apprehension, anxiety, emotional distress, coping related surveillance. Conclusions: appear result. Future research should determine impact on programs.

Язык: Английский

Процитировано

37

Hepatocellular carcinoma DOI
Cristina Dopazo, Kjetil Søreide, Elena Rangelova

и другие.

European Journal of Surgical Oncology, Год журнала: 2023, Номер 50(1), С. 107313 - 107313

Опубликована: Дек. 6, 2023

Язык: Английский

Процитировано

29

Financial Burden of Hepatocellular Carcinoma Screening in Patients With Cirrhosis DOI
Manasa Narasimman, Rubén Hernáez,

Vanessa Cerda

и другие.

Clinical Gastroenterology and Hepatology, Год журнала: 2023, Номер 22(4), С. 760 - 767.e1

Опубликована: Авг. 6, 2023

Язык: Английский

Процитировано

26

Hypoxia-induced circ-CDYL-EEF1A2 transcriptional complex drives lung metastasis of cancer stem cells from hepatocellular carcinoma DOI Open Access
Ruijiao Kong,

Wenxin Wei,

Qiuhong Man

и другие.

Cancer Letters, Год журнала: 2023, Номер 578, С. 216442 - 216442

Опубликована: Окт. 16, 2023

Язык: Английский

Процитировано

23